First human tests for new drug halted early
NCT ID NCT06910709
Summary
This early-stage study aimed to check the safety of a new drug called AMG 378 and see how the body absorbs and processes it. It involved 48 healthy adults who received either the drug or a placebo. The trial was terminated, meaning it was stopped early, and its main goal was to gather initial safety information, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
-
Orange County Research Center
Lake Forest, California, 92630, United States
Conditions
Explore the condition pages connected to this study.